Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- [Ca]c oscillations
- Agonist specificity
- Routes of Ca movement
- How is [Ca]c elevated?
- How is [Ca]c decreased?
- Plasma membrane Ca efflux is the least studied
- Ca efflux across the plasma membrane
- Ca efflux across the plasma membrane: NCX
- Ca efflux across the plasma membrane: PMCA
- Ca efflux from rat hepatocytes
- Carboxyeosin and mini-glucagon
- Carboxyeosin and Phe-induced oscillations
- Carboxyeosin and ATP-induced oscillations
- Mini-glucagon and Phe-induced oscillations
- Mini-glucagon and ATP-induced oscillations
- PMCA inhibitors increase oscillation frequency
- Removal of extracellular Ca and oscillations
- Inhibition of plasma membrane Ca efflux
- [Ca]c oscillations in smooth muscle cells
- Decrease of plasma membrane Ca influx
- Net plasma membrane Ca flux
- Mini-glucagon is agonist for hepatocytes
- Atrial natriuretic peptide (ANP)
- ANP acts on the GC-A receptor
- ANP stimulates cGMP production
- ANP and 8-Br-cGMP stimulate Ca efflux
- ANP partially inhibits basal cation influx
- Neither ANP nor 8-Br-cGMP elevate [Ca]c
- ANP and Phe-induced oscilations
- ANP and ATP-induced oscilations
- 8-Br-cGMP and Phe-induced oscilations
- Major observation regarding ANP
- Plasma membrane Ca flux and oscillations
- [Ca]c waves
- The model
- Mini-glucagon inhibits Ca efflux
- Mini-glucagon increases Ca oscillation frequency
- ANP stimulates Ca efflux
- ANP attenuates oscillations
- Ca efflux modulators
- Brain natriuretic peptide
- CD22
- Ca efflux modulators and downstream processes
- Frequency-modulation of [Ca]i oscillations
- Conclusion
- References
- Acknowledgements
Topics Covered
- Introduction to [Calcium]c oscillations
- Involvement of Calcium fluxes in [Calcium]c oscillations
- Plasma membrane Calcium efflux
- Impact of Calcium efflux inhibition on [Calcium]c oscillations
- Mini-glucagon as a physiological Calcium efflux inhibitor
- Atrial natriuretic peptide as a physiological Calcium efflux stimulator
- A hypothetical mechanism for plasma membrane Calcium flux as a determinant of [Calcium]c oscillation frequency
- 'Calcium efflux modulators': a class of physiological agonists?
Talk Citation
Green, A. (2007, October 1). Ca2+ efflux and Ca2+ signals [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/QWZG1902.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Anne Green has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.